title: Trans-vivo delayed type hypersensitivity assay for antigen specific regulation.
abstract: Delayed-type hypersensitivity response (DTH) is a rapid in vivo manifestation of T cell-dependent immune response to a foreign antigen (Ag) that the host immune system has experienced in the recent past. DTH reactions are often divided into a sensitization phase, referring to the initial antigen experience, and a challenge phase, which usually follows several days after sensitization. The lack of a delayed-type hypersensitivity response to a recall Ag demonstrated by skin testing is often regarded as an evidence of anergy. The traditional DTH assay has been effectively used in diagnosing many microbial infections. Despite sharing similar immune features such as lymphocyte infiltration, edema, and tissue necrosis, the direct DTH is not a feasible diagnostic technique in transplant patients because of the possibility of direct injection resulting in sensitization to donor antigens and graft loss. To avoid this problem, the human-to-mouse "trans-vivo" DTH assay was developed (1,2). This test is essentially a transfer DTH assay, in which human peripheral blood mononuclear cells (PBMCs) and specific antigens were injected subcutaneously into the pinnae or footpad of a naïve mouse and DTH-like swelling is measured after 18-24 hr (3). The antigen presentation by human antigen presenting cells such as macrophages or DCs to T cells in highly vascular mouse tissue triggers the inflammatory cascade and attracts mouse immune cells resulting in swelling responses. The response is antigen-specific and requires prior antigen sensitization. A positive donor-reactive DTH response in the Tv-DTH assay reflects that the transplant patient has developed a pro-inflammatory immune disposition toward graft alloantigens. The most important feature of this assay is that it can also be used to detect regulatory T cells, which cause bystander suppression. Bystander suppression of a DTH recall response in the presence of donor antigen is characteristic of transplant recipients with accepted allografts (2,4-14). The monitoring of transplant recipients for alloreactivity and regulation by Tv-DTH may identify a subset of patients who could benefit from reduction of immunosuppression without elevated risk of rejection or deteriorating renal function. A promising area is the application of the Tv-DTH assay in monitoring of autoimmunity(15,16) and also in tumor immunology (17).
authors.affiliation: Department of Surgery, University of Wisconsin-Madison, School of Medicine and Public Health, USA.
authors.forename: Ewa
authors.initials: E
authors.lastname: Jankowska-Gan
authors.forename: Subramanya
authors.initials: S
authors.lastname: Hegde
authors.forename: William J
authors.initials: WJ
authors.lastname: Burlingham
mesh_terms: D000818:Animals; D000941:Antigens / Q000008:administration & dosage / Q000276:immunology*; D015551:Autoimmunity; D000939:Epitopes; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007159:Immunologic Tests / Q000379:methods*; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000379:methods; D007963:Leukocytes, Mononuclear / Q000276:immunology; D051379:Mice; D023421:Models, Animal; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D014181:Transplantation Immunology
chemical_list: D000941:Antigens; D000939:Epitopes